European dairy and nutrition major Danone SA is banking on its nutrition business to be the “star performer” for its India operations. It will also look to ramp up its India business with focus on the nutrition and dairy segment.

Globally, Danone has four major verticals that include dairy offerings, beverages, early life nutrition and advance medical nutrition.

In India, it operates in two of the verticals – dairy and early life nutrition – and is eyeing an entry into the third category of advance medical nutrition, according to Rodrigo Lima, Managing Director of the company’s India arm.

The company has so far invested ₹1,800 crore in India and is targeting a 30 per cent growth in advertising and marketing spends this year.

Besides launching products in the existing infant foods business, the maker of Farex (baby food) and Protinex supplements will introduce global brands in the advance medical nutrition business too.

While the company has introduced one global brand, “Aptamil” – an infant brand – in January, the plan now is to introduce at least 10 other global brands and enter the advance medical nutrition business by “mid of this year”.

On cards is the launch of Neocate, a hypoallergenic medical nutrition product for infants and children with diagnosed allergies and a range of specialised food for “inborn errors of metabolism”.

“Our target is to double India revenues by 2020, with nutrition being the star performer. We intend to launch 10 brands here in 2017,” Lima told BusinessLine during an interview.

He was in the city to launch Protinex Grow, catering to the health food drinks segment for adolescents.

comment COMMENT NOW